UPDATE - US panel backs new claim for Pfizer lung drug (at Reuters)
FDA advisers back new benefit claim for Spiriva * Panel says safety data adequate * Pfizer shares fall 8 cents (Adds panel member, company quotes; updates shares) By Lisa Richwine SILVER SPRING, Md., Nov 19 (Reuters) - Pfizer...



